Holen Sie sich die Stockscreener-App
0.50
0.70%
-0.0035
Finanzdaten der Bolt Biotherapeutics Inc-Aktie (BOLT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
152.47%
5.274
|
2.089 | 2.528 | 1.433 | 1.826 |
Operating Expenses
|
2.34%
22.37
|
21.86 | 20.71 | 21.27 | 20.24 |
| Benefits Costs and Expenses |
19.54%
16.09
|
19.99 | - | - | 18.81 |
| Costs And Expenses |
19.54%
16.09
|
19.99 | 20.71 | 21.27 | 18.81 |
| Operating Income/Loss |
13.53%
-17.09
|
-19.77 | -18.18 | -19.83 | -18.41 |
| Nonoperating Income/Loss |
237.14%
6.281
|
1.863 | 1.926 | 1.775 | 1.435 |
| Income/Loss From Continuing Operations Before Tax |
39.61%
-10.81
|
-17.90 | 2.528 | 1.433 | -16.98 |
| Income/Loss From Continuing Operations After Tax |
39.61%
-10.81
|
-17.90 | -16.26 | -18.06 | -16.98 |
|
Net Income/Loss
|
39.61%
-10.81
|
-17.90 | -16.26 | -18.06 | -16.98 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
87,061%
38.07
|
0.0437 | 37.87 | 37.75 | 37.68 |
| Diluted Average Shares |
87,061%
38.07
|
0.0437 | 37.87 | 37.75 | 37.68 |
| Basic Earnings Per Share |
40.43%
-0.28
|
-0.47 | -0.43 | -0.48 | -0.45 |
| Diluted Earnings Per Share |
40.43%
-0.28
|
-0.47 | -0.43 | -0.48 | -0.45 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):